Loading...
•
Jun 30, 2021
AMN Healthcare Q2 2021 Earnings Report
Second quarter financial performance surpassed guidance, driven by robust demand and effective team execution, with revenue up 41% year-over-year.
Key Takeaways
AMN Healthcare reported a strong second quarter in 2021, with revenue of $857 million, a 41% increase over the prior year. GAAP EPS was $1.39, and adjusted EPS was $1.64. The company benefited from increased healthcare utilization and a tight labor market, leading to record high demand.
Second quarter financial performance exceeded guidance due to strong demand and team execution.
Healthcare utilization increase and tight labor market drove record high demand.
Revenue reached $857 million, a 41% increase year-over-year.
Operating cash flow for the first half of 2021 was $211 million, up 64% year-over-year.
AMN Healthcare
AMN Healthcare
AMN Healthcare Revenue by Segment
Revenue by Segment
Nurse and Allied Solutions Revenue
CapyFin.comPhysician and Leadership Solutions Revenue
CapyFin.comTechnology and Workforce Solutions Revenue
CapyFin.com Forward Guidance
The company expects revenue between $770 and $790 million. Gross margin is expected to be between 33.4% and 33.9%.
Positive Outlook
- Consolidated revenue is expected to be 40-43% higher than prior year.
- Nurse and Allied Solutions segment revenue is expected to grow approximately 45% year over year.
- Physician and Leadership Solutions segment revenue is expected to be 25-27% higher than prior year.
- Technology and Workforce Solutions segment revenue is expected to grow by 44-48% compared with the year-ago period.
- Revenue guidance includes approximately $20 million from labor disruption-related activities.
Challenges Ahead
- SG&A as percentage of revenue: 19.8% - 20.2%
- Operating margin: 10.0% - 10.5%
- Adjusted EBITDA margin: 14.2% - 14.7%
- Depreciation of $10 million.
- Interest expense of $10 million
Revenue & Expenses
Visualization of income flow from segment revenue to net income